Silvia von Karstedt
Affiliation: University of Cologne
Kretz A, Trauzold A, Hillenbrand A, Knippschild U, Henne Bruns D, von Karstedt S, et al
. TRAILblazing Strategies for Cancer Treatment. Cancers (Basel). 2019;11: pubmed publisher
..Moreover, we provide an overview and outlook on innovative and promising future TRAIL-based therapeutic strategies. ..
García Reyes B, Kretz A, Ruff J, von Karstedt S, Hillenbrand A, Knippschild U, et al
. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma. Int J Mol Sci. 2018;19: pubmed publisher
..Here, we review the current knowledge of CDK biology, its role in cancer and the therapeutic potential to target CDKs as a novel treatment strategy for PDAC. ..
Kretz A, von Karstedt S, Hillenbrand A, Henne Bruns D, Knippschild U, Trauzold A, et al
. Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy. Cancers (Basel). 2018;10: pubmed publisher
..In this review, we summarize the status quo of clinical studies involving TRAIL-R agonists for the treatment of pancreatic cancer and critically discuss the suitability of utilizing the TRAIL-TRAIL-R system for successful treatment. ..